Status of propranolol for treatment of infantile hemangioma and description of a randomized clinical trial

Annals of Otology, Rhinology and Laryngology

Volumn 120, Issue 10, 2011, Pages 686-695

  Menezes, Maithilee D ^a   McCarter, Robert ^b   Greene, E Anne ^b   Bauman, Nancy M ^b  

^a Feldman ENT Group   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Acebutolol; Hemangioma; Propranolol; Review

Indexed keywords

ACEBUTOLOL; PREDNISOLONE; PROPRANOLOL;

AGITATION; ASTHMA; BRADYCARDIA; BRONCHIOLITIS; CAPILLARY HEMANGIOMA; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; GASTROESOPHAGEAL REFLUX; HUMAN; HYPOGLYCEMIA; HYPOTENSION; INSOMNIA; NIGHT SWEAT; NIGHTMARE; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RELAPSE; REVIEW; SEIZURE; SIDE EFFECT; SINGLE BLIND PROCEDURE; SOMNOLENCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WHEEZING;

EID: 80053923852     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348941112001010     Document Type: Review

References (54)

1. Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol 2008;25:168-73. (Pubitemid 351579596)
2. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006;188:882-7. (Pubitemid 46091612)
3. Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008;122:360-7.
4. Bruckner AL, Frieden IJ. Hemangiomas of infancy. J Am Acad Dermatol 2003;48:477-93. (Pubitemid 36397008)
5. Bowers RE, Graham EA, Tomlinson KM. The natural history of the strawberry nevus. Arch Dermatol 1960;82:667-80.
6. Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med 1999;341:173-81. (Pubitemid 29325746)
7. Enjolras O, Gelbert F. Superficial hemangiomas: associations and management. Pediatr Dermatol 1997;14:173-9. (Pubitemid 27255859)
8. Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 1983;18:894-900. (Pubitemid 14175292)
9. Blei F, Chianese J. Corticosteroid toxicity in infants treated for endangering hemangiomas: experience and guidelines for monitoring. Int Pediatr 1999;14:146-53.
10. Frieden IJ, Eichenfield LF, Esterly NB, Geronemus R, Mallory SB. Guidelines of care for hemangiomas of infancy. J Am Acad Dermatol 1997;37:631-7. (Pubitemid 27446736)
11. Bennett ML, Fleischer AB Jr, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 2001;137:1208-13. (Pubitemid 32847844)
12. Melo-Gomes JA. Problems related to systemic glucocorticoid therapy in children. J Rheumatol Suppl 1993;37:35-9. (Pubitemid 23128481)
13. Enjolras O, Brevière GM, Roger G, et al. Vincristine treatment for function- and life-threatening infantile hemangioma [in French]. Arch Pediatr 2004;11:99-107. (Pubitemid 38220704)
14. Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998;132:527-30. (Pubitemid 28180264)
15. Michaud AP, Bauman NM, Burke DK, Manaligod JM, Smith RJ. Spastic diplegia and other motor disturbances in infants receiving interferon-alpha. Laryngoscope 2004;114:1231-6. (Pubitemid 38954577)
16. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51. (Pubitemid 351831393)
17. Buckmiller L, Dyamenahalli U, Richter GT. Propranolol for airway hemangiomas: case report of novel treatment. Laryngoscope 2009;119:2051-4.
18. Bonifazi E, Colonna V, Mazzotta F, Balducci G, Laforgia N. Propranolol in rapidly growing hemangiomas. Eur J Pediatr Dermatol 2008;18:185-92.
19. Sans V, de la Roque ED, Berge J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009;124:e423-e431.
20. Theletsane T, Redfern A, Raynham O, Harris T, Prose NS, Khumalo NP. Life-threatening infantile haemangioma: a dramatic response to propranolol. J Eur Acad Dermatol Venereol 2009;23:1465-6.
21. Wachter K. More data add to propranolol buzz. Skin & Allergy News, May 2009.
22. Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med 2008;359:2846-7.
23. Artman M, Grayson M, Boerth RC. Propranolol in children: safety-toxicity. Pediatrics 1982;70:30-1. (Pubitemid 12078070)
24. Buckmiller LM. Propranolol treatment for infantile hemangiomas. Curr Opin Otolaryngol Head Neck Surg 2009;17:458-9.
25. Buckmiller LM, Munson PD, Dyamenahalli U, Dai Y, Richter GT. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope 2010;120:676-81.
26. Holmes WJ, Mishra A, Gorst C, Liew SH. Propranolol as first-line treatment for infantile hemangiomas. Plast Reconstr Surg 2010;125:420-1.
27. Manunza F, Syed S, Laguda B, et al. Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol 2010;162:466-8.
28. Tan ST, Itinteang T, Leadbitter P. Low-dose propranolol for infantile hemangioma. J Plast Reconstr Aesthet Surg 2011;64:292-9.
29. Leboulanger N, Fayoux P, Teissier N, et al. Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: a preliminary retrospective study of French experience. Int J Pediatr Otorhinolaryngol 2010;74:1254-7.
30. Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 2009;26:610-4.
31. Itani MH, Fakih H. Response of facial haemangioma to oral propranolol. BMJ Case Reports 2009; doi:10.1136/bcr.01.2009.1476.
32. Marsciani A, Pericoli R, Alaggio R, Brisigotti M, Vergine G. Massive response of severe infantile hepatic hemangioma to propranolol. Pediatr Blood Cancer 2010;54:176.
33. Taban M, Goldberg RA. Propranolol for orbital hemangioma. Ophthalmology 2010;117:195-195.e4.
34. Fay A, Nguyen J, Jakobiec FA, Meyer-Junghaenel L, Waner M. Propranolol for isolated orbital infantile hemangioma. Arch Ophthalmol 2010;128:256-8.
35. Bonifazi E, Acquafredda A, Milano A, Montagna O, Laforgia N. Severe hypoglycemia during successful treatment of diffuse hemangiomatosis with propranolol. Pediatr Dermatol 2010;27:195-6.
36. Maturo S, Hartnick C. Initial experience using propranolol as the sole treatment for infantile airway hemangiomas. Int J Pediatr Otorhinolaryngol 2010;74:323-5.
37. Mistry N, Tzifa K. Use of propranolol to treat multicentric airway haemangioma. J Laryngol Otol 2010;124:1329-32.
38. Vanlander A, Decaluwe W, Vandelanotte M, Van Geet C, Cornette L. Propranolol as a novel treatment for congenital visceral haemangioma. Neonatology 2010;98:229-31.
39. Holland KE, Frieden IJ, Frommelt PC, Mancini AJ, Wyatt D, Drolet BA. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol 2010;146:775-8.
40. Rosbe KW, Suh KY, Meyer AK, Maguiness SM, Frieden IJ. Propranolol in the management of airway infantile hemangiomas. Arch Otolaryngol Head Neck Surg 2010;136:658-65.
41. Blanchet C, Nicollas R, Bigorre M, Amedro P, Mondain M. Management of infantile subglottic hemangioma: acebutolol or propranolol? Int J Pediatr Otorhinolaryngol 2010;74:959-61.
42. Canadas KT, Baum ED, Lee S, Ostrower ST. Case report: treatment failure using propranolol for treatment of focal subglottic hemangioma. Int J Pediatr Otorhinolaryngol 2010;74:956-8.
43. Mazereeuw-Hautier J, Hoeger PH, Benlahrech S, et al. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. J Pediatr 2010;157:340-2.
44. Naouri M, Schill T, Maruani A, Bross F, Lorette G, Rossler J. Successful treatment of ulcerated haemangioma with propranolol. J Eur Acad Dermatol Venereol 2010;24:1109-12.
45. Cheng JF, Gole GA, Sullivan TJ. Propranolol in the management of periorbital infantile haemangioma. Clin Experiment Ophthalmol 2010;38:547-53.
46. Li YC, McCahon E, Rowe NA, Martin PA, Wilcsek GA, Martin FJ. Successful treatment of infantile haemangiomas of the orbit with propranolol. Clin Experiment Ophthalmol 2010; 38:554-9.
47. Truong MT, Perkins JA, Messner AH, Chang KW. Propranolol for the treatment of airway hemangiomas: a case series and treatment algorithm. Int J Pediatr Otorhinolaryngol 2010;74:1043-8.
48. Fulkerson DH, Agim NG, Al-Shamy G, Metry DW, Izaddoost SA, Jea A. Emergent medical and surgical management of mediastinal infantile hemangioma with symptomatic spinal cord compression: case report and literature review. Childs Nerv Syst 2010;26:1799-805.
49. Breur JM, de Graaf M, Breugem CC, Pasmans SG. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report. Pediatr Dermatol 2011;28:169-71.
50. http://www.pharmacyreviewer.com/site-v1/forum/beta-blockers/ 10306-has-anyone-used-propranolol-treating-hemangioma-8.html. Accessed August 13, 2010.
51. Physicians' desk reference. 65th ed. Montvale, NJ: PDR Network, LLC, 2011.
52. Frieden IJ, Drolet BA. Propranolol for infantile hemangiomas: promise, peril, pathogenesis. Pediatr Dermatol 2009;26:642-4.
53. Propranolol vs. prednisolone for treatment of symptomatic hemangiomas. ClinicalTrials.gov identifier NCT00967226.
54. Propranolol in capillary hemangiomas. ClinicalTrials. gov identifier NCT00744185.